Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Systemic mastocytosis without the typical mutation of codon 816 successfully treated with imatinib].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine - 10 Oct 2008

Hirayama Yasuo, Konuma Yuich, Kohda Kyuhei, Ando Masakatsu, Obata Masahiko, Ueno Yoshinori, Sasagawa Yutaka, Wada Yuko, Shirao Sayaka

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzamides
Share to Codon
Share to Imatinib Mesylate
Share to Mastocytosis, Systemic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Piperazines

Share to Protein Kinase Inhibitors

Share to Proto-Oncogene Proteins c-kit

Share to Pyrimidines

Source

Identifiers

PMID: 19051746
DOI: 10.2169/naika.97.2542

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Systemic mastocytosis without the typical mutation of codon 816 successfully treated with imatinib].PMID 19051746Read ↗

[Systemic mastocytosis. Classification, symptoms, therapy].Semantic proximity Read ↗

[Current concepts and treatment advances in systemic mastocytosis].Semantic proximity Read ↗

[Neoplastic mastocytosis evolving from a poor prognosis acute myeloid leukemia].Semantic proximity Read ↗

Recent advances in the understanding and therapeutic management of mastocytosisSemantic proximity Read ↗

Systemic Mastocytosis: State of the Art.Semantic proximity Read ↗

[Mastocytosis or piebaldism--the KIT mutation decides].Semantic proximity Read ↗

[Pathogenesis, diagnosis and treatment of mastocytosis].Semantic proximity Read ↗

[Mastocytosis].Semantic proximity Read ↗

[Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis].Semantic proximity Read ↗

De novo leukemic variant of mast cell leukemia with KIT D816V.Semantic proximity Read ↗

Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 <i>KIT</i> mutations and review of the literatureSemantic proximity Read ↗

Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.